The IMPACT+ project aims to evaluate the cost-effectiveness of mass ivermectin administration as a comprehensive intervention against malaria and several neglected tropical diseases (NTDs), including onchocerciasis, lymphatic filariasis, soil-transmitted helminthiasis, scabies, and pediculosis. The research builds on recent results from the BOHEMIA trial, which demonstrated that ivermectin significantly reduces the incidence of malaria and other parasitic diseases when administered at the community level.

Currently, malaria and neglected tropical disease control programs are implemented primarily through vertical approaches, without adequately assessing cross-cutting benefits or operational synergies.

This project addresses the need to generate integrated evidence that allows for the optimization of resource allocation in resource-limited settings, providing relevant information for decision-making by ministries of health and international funding agencies.iadores internacionales.

TEAM